Company / Inventory
GYRE THERAPEUTICS, INC. Inventory History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$6.3M
FY2024
5-year range
$4.3M / $6.3M
FY2022-FY2024
Trend
+48.0%
vs FY2023
Sector context
#92 of 105
Health Care
What the data says
GYRE THERAPEUTICS, INC.'s inventory of $6M is lower than 88% of companies in the Health Care sector (FY2024). Improved from $6M to $6M over the past 2 years.
Based on SEC 10-K filings.
$6M in FY2024.
Improved from $6M to $6M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 105This company $6.3M Sector average $885.3M
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2024, inventory increased 48.0% year-over-year.
- Ranks #92 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $6.3M | +48.0% |
| FY2023 | $4.3M | -30.1% |
| FY2022 | $6.1M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026